TIDMIDHC
RNS Number : 4666D
Integrated Diagnostics Holdings PLC
21 June 2023
IDH appoints new Chief Financial Officer and Strategic
Investment Officer
21 June 2023
(Cairo and London) - Integrated Diagnostics Holdings ("IDH,"
"the Group," or "the Company"), a leading provider of diagnostics
services with operations in Egypt, Jordan, Nigeria and Sudan,
announces the appointment of Ahmed El Gebeily as Group Chief
Financial Officer, effective 15 August 2023. His appointment will
follow the departure of IDH's long-term VP Finance and Strategies
and Group Chief Financial Officer, Omar Bedewy, on 30 June 2023.
Bedewy has been with IDH since 2016 and has played a vital role in
the Company's growth and expansion in recent years. IDH is also
excited to announce the appointment of Sherif El Etreby, who will
fill the role of Group Strategic Investment Officer, effective 15
August 2023.
During the transition, Bedewy, along with the rest of IDH's
management team, is committed to ensuring an efficient handover of
responsibilities, remaining diligent in the Company's transitional
phase until El Gebeily effectively assumes his role as Group Chief
Financial Officer. Following Bedewy's departure, Ahmed Sileem will
fill the position of Interim Chief Financial Officer until El
Gebeily fills the role on 15 August 2023. Sileem currently serves
as Regional Financial Controller at IDH and has been with the
Company since 2012.
El Etreby, filling the new role of Group Strategic Investment
Officer, will be responsible for developing and directing the
Group's strategy pillars and long-term outlook, identifying
potential opportunities for business expansion. This new position
was created in line with IDH's continuous efforts to identify and
maximise long-term growth across its current and potential
markets.
Dr. Hend El Sherbini, Group Chief Executive Officer, commented:
"On behalf of IDH's Board of Directors and management team, I would
like to thank Omar for his invaluable contributions to the Company
over the past seven years, and his pivotal role in our growth
story. Omar has been an exceptional leader within IDH's walls since
he first joined in 2016 and has helped navigate the Company through
some of its most challenging times. We wish him all the best in his
future endeavours.
"In the coming weeks, and along with the rest of the management
team, I will prioritize the smooth continuation of all our business
operations, as well as safeguard an effective handover to our next
CFO, who will surely continue to play as pivotal a role as Omar has
in the past years. I am excited at the level of experience that
both additions to our management team bring with them. Both Ahmed
and Sherif are experienced executives with unique skills and
expertise, and I have the utmost confidence in their ability to
further guide IDH in its future growth plans and their ability to
lead within the IDH family. The addition of the Strategic
Investment Officer role to our team marks a new era for IDH, and
further reaffirms our commitment to delivering strategic growth
wherever possible." Dr. Hend added.
Commenting on his departure, Omar Bedewy, Chief Financial
Officer, said: "I am truly grateful for the incredible journey I
have had during my tenure at IDH. It has been an absolute privilege
working alongside a talented and dedicated team throughout the
years. Together, we have accomplished remarkable milestones that
have cemented our position as a leading healthcare provider in all
our markets. Over the coming weeks, I remain committed to seeing
the full handover of my roles and responsibilities to my successor
to ensure continued success for IDH under his guidance.
"As I move on from my role, I want to express my heartfelt
wishes for IDH's continued success and future growth. I have the
utmost confidence in the organization's ability to navigate the
evolving healthcare landscape and continue to make great strides in
the future. I will continue to follow IDH's progress and celebrate
its achievements with immense pride as it continues touching lives
and remaining on the front lines providing quality healthcare in
the region." He added.
Ahmed El Gebeily Bio
El Gebeily is a senior executive finance director with nearly
three decades of experience and a successful track record in
business start-ups in various international and local settings,
including construction, building material industries, among others.
He currently serves as the Chief Financial Officer at Egyptian
Industrial Investment Group.
His previous experiences include Senior Executive Finance
Director at Egyptian Steel Group, Regional Finance Director at
Lafarge Middle East and Africa, and Head of Finance for New
Projects at Orascom Industries - Cement Division. Prior to these
roles, El Gebeily held several positions with Kharafi Group, where
he was stationed in several countries, including Albania, Syria,
South Africa and Mozambique.
He boasts a unique set of skills and experience, including
experience in company management, holding restructuring and
liquidation, designing accounting systems, ERP implementation, and
company registration processes.
During his tenure, he gained strong exposure in acquisitions,
due diligence, post-purchase audits, joint venture management, sale
and purchase agreements (SPA), shareholders loan agreements, as
well as the management and setup of full Financial Shared Services
Centre (FSSC), both locally and regionally.
El Gebeily's skills also include project financial management,
costing and contract negotiation, and closure. He is an expert with
internal control functions, budget monitoring, and performance
analysis, as well as corrective measure implementation. He has
strong experience in tax optimisation, tax disputes, and tax
refunds in several countries. Finally, El Gebeily is skilled at
knowledge transferring, team building, and training future
generations for leadership positions.
Sherif El Etreby Bio
El Etreby is a seasoned financial executive with over 25 years
of experience in the financial field, boasting several significant
roles and major achievements in banking institutions for 10 years.
He currently serves as the Senior Vice President of Investments at
Egyptian Industrial Investment Group.
El Etreby's previous experiences include nine years as the
Senior Planning Executive at Egyptian Steel Group, as well as a
member of the founding team of Egyptian Cement Company during the
same period. Prior to those roles, he served as the Regional
Controller for Special Projects - Middle East and Africa at
Lafarge, as well as Deputy Regional Business Controller for North
Africa and Head of Planning at Orascom Construction - Cement
Sector.
He has been involved in major syndication loans facilities,
acquisitions, and divestments in the cement and steel sectors in
the Middle East and Africa, including the acquisition of Lafarge to
Orascom Construction Industries - Cement Sector in 2008. He was
also involved in the sell down of the founder's stack in Egyptian
Steel Group to Al Ezz Dekheila Steel Co. in 2021.
-Ends-
About Integrated Diagnostics Holdings (IDH)
IDH is a leading diagnostics services provider in the Middle
East and Africa offering a broad range of pathology and radiology
tests to patients in Egypt, Jordan, Nigeria and Sudan. The Group's
core brands include Al Borg, Al Borg Scan and Al Mokhtabar in
Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan
(both in Sudan) and Echo-Lab (Nigeria). A long track record for
quality and safety has earned the Company a trusted reputation, as
well as internationally recognised accreditations for its portfolio
of over 2,000 diagnostics tests. From its base of 552 branches as
of 31 December 2022, IDH served over 8.7 million patients and
performs more than 32.7 million tests in 2022. IDH will continue to
add laboratories through a Hub, Spoke and Spike business model that
provides a scalable platform for efficient expansion. Beyond
organic growth, the Group's expansion plans include acquisitions in
new Middle Eastern, African, and East Asian markets where its model
is well-suited to capitalise on similar healthcare and consumer
trends and capture a significant share of fragmented markets. IDH
has been a Jersey-registered entity with a Standard Listing on the
Main Market of the London Stock Exchange (ticker: IDHC) since May
2015 with a secondary listing on the EGX since May 2021 (ticker:
IDHC.CA).
Learn more at idhcorp.com .
Contact
Nancy Fahmy
Investor Relations Director
T: +20 (0)2 3345 5530 | M: +20 (0)12 2255 7445 |
nancy.fahmy@idhcorp.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAPPUAGQUPWGUG
(END) Dow Jones Newswires
June 21, 2023 06:18 ET (10:18 GMT)
Integrated Diagnostics (LSE:IDHC)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Integrated Diagnostics (LSE:IDHC)
Gráfica de Acción Histórica
De May 2023 a May 2024